Brunswick vs MarineMax
BC and HZO side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BC and HZO compare
Brunswick is the larger company, worth 4.2 times as much as MarineMax ($4.9B against $1.2B).
Brunswick grew revenue faster over the last twelve months (10.5% versus −5.4% for MarineMax).
MarineMax keeps more of each dollar of sales as profit, with a net margin of 0.18% compared with −1.5% at Brunswick.
Brunswick pays a dividend yielding 2.3%; MarineMax does not pay one.
Brunswick scores higher on the StockData Score (7 against 5 for MarineMax), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BC | HZO |
|---|---|---|
| Size and price | ||
| Market cap | $4.9B | $1.2B |
| Share price | $75.34 | $52.76 |
| Change, 1 year | 10.2% | 115% |
| Change, 5 years | −24.8% | −4.5% |
| Beta (5Y) | 1.22 | 1.37 |
| Employees | 14K | 3,385 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 2 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | – | 377× |
| P/S | 0.9× | 0.5× (better) |
| P/B | 2.9× | 1.2× (better) |
| EV/EBITDA | 24.1× | 16.8× (better) |
| P/FCF | 14.3× | 6.5× (better) |
| FCF yield | 7.0% | 15.3% (better) |
| Fair value | $39.88 | – |
| Margin of safety | −88.9% | – |
| Growth | ||
| Revenue growth (TTM) | 10.5% (better) | −5.4% |
| Revenue growth, 5Y average | 4.3% | 8.9% (better) |
| Net income growth (TTM) | −307% | – |
| EPS growth (TTM) | −310% | – |
| Profitability | ||
| Gross margin | 25.6% | 34.2% (better) |
| Operating margin | −0.37% | 3.0% (better) |
| Net margin | −1.5% | 0.18% (better) |
| FCF margin | 6.1% | 8.1% (better) |
| Return on equity | −4.8% | 0.42% (better) |
| Return on invested capital | −0.44% | 3.6% (better) |
| Financial health | ||
| Debt / equity | 1.25 | 1.02 (better) |
| Net debt / EBITDA | 6.54 (better) | 6.77 |
| Interest coverage | −0.2× | 1.1× (better) |
| Current ratio | 1.45 (better) | 1.23 |
| Altman Z-score | 2.80 (better) | 2.08 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% | – |
| Years of dividend growth | 13 | – |
| Dividend growth, 5Y average | 11.7% | – |
| Buyback yield | 1.4% | – |
| Shareholder yield | 3.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 106% | 89.4% |
| Held by insiders | 1.6% | 9.7% |
| Insider net buying, 12 months | −$7.1M | – |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 8.5% | 9.9% |
Go deeper
- BC stock overview
- BC income statement
- BC valuation and score
- HZO stock overview
- HZO income statement
- HZO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.